… The predominantly relapsing and often severe disease course and the short median time
to second attack support the use of prophylactic long-term treatments in patients with MOG-IgG-…

… Serum MOG-IgG is present already at disease onset and remains detectable in the long-…
ON and/or myelitis as well as treatment responses and long-term outcome [36]. In part 3, we …

… Neuromyelitis optica (NMO, Devic’s syndrome), long considered a clinical variant of multiple
… increasingly regarded as an established therapy with long-term efficacy and an acceptable …

… make predictions at arbitrary longer times kτ, with k ≥ 1. f denotes some function of interest
given for the model M(τ), and f̃ (k) [M(τ)] denotes the model prediction of f for a longer time kτ; …

… Patients without long-term immunosuppressive therapy have a worse prognosis with a
higher mortality rate (17). Disease onset ranges between 4 and 88 years with a mean age at …

… Longer imaging sessions are possible with our setup; however, we limited the imaging time
window to 20 min to avoid possible side effects due to mechanical stress or long-term laser …

In this paper, the potential that organometallic architectures consisting of two transition metal
centers linked by an organic unsaturated spacer present for the study and development of …

… of 18,000 m2 to provide high sensitivity and which were operated at the long wavelength of
3.7 m, because the fluctuations were known to be more prominent at the longer wavelengths. …

… We hypothesized that in clinical practice, longer DB-DN times would be associated with …
Longer DB-DN times were associated with increased mortality (P<0.0001). The DB-DN time …

… and an order of magnitude more than characteristic long-term averages since the end of the
… This constitutes a serious challenge for long-term monitoring programmes (Paul and others, …